Telomerase: A potential molecular marker and therapeutic target for cancer

被引:14
作者
Chang, JY [1 ]
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Radiat Oncol, Unit 97, Houston, TX 77030 USA
关键词
D O I
10.1002/jso.20076
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1 / 3
页数:3
相关论文
共 17 条
[1]   hTERT promoter induces tumor-specific Bax gene expression and cell killing in syngenic mouse tumor model and prevents systemic toxicity [J].
Gu, J ;
Andreeff, M ;
Roth, JA ;
Fang, B .
GENE THERAPY, 2002, 9 (01) :30-37
[2]  
Gu J, 2000, CANCER RES, V60, P5359
[3]   Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death [J].
Herbert, BS ;
Pitts, AE ;
Baker, SI ;
Hamilton, SE ;
Wright, WE ;
Shay, JW ;
Corey, DR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (25) :14276-14281
[4]   Effects of chemopreventive and antitelomerase agents on the spontaneous immortalization of breast epithelial cells [J].
Herbert, BS ;
Wright, AC ;
Passons, CM ;
Wright, WE ;
Ali, IU ;
Kopelovich, L ;
Shay, JW .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (01) :39-45
[5]   Clinical utility of telomerase in cancer [J].
Eiso Hiyama ;
Keiko Hiyama .
Oncogene, 2002, 21 (4) :643-649
[6]   A novel conditionally replicative adenovirus vector targeting telomerase-positive tumor cells [J].
Huang, Q ;
Zhang, XW ;
Wang, H ;
Yan, B ;
Kirkpatrick, J ;
Dewhrist, MW ;
Li, CY .
CLINICAL CANCER RESEARCH, 2004, 10 (04) :1439-1445
[7]   Suppressing orthotopic pancreatic tumor growth with a fiber-modified adenovector expressing the TRAIL gene from the human telomerase reverse transcriptase promoter [J].
Jacob, D ;
Davis, J ;
Zhu, HB ;
Zhang, LD ;
Teraishi, F ;
Wu, SH ;
Marini, FC ;
Fang, BL .
CLINICAL CANCER RESEARCH, 2004, 10 (10) :3535-3541
[8]   A novel telomerase-specific gene therapy: Gene transfer of caspase-8 utilizing the human telomerase catalytic subunit gene promoter [J].
Koga, S ;
Hirohata, S ;
Kondo, Y ;
Komata, T ;
Takakura, M ;
Inoue, M ;
Kyo, S ;
Kondo, S .
HUMAN GENE THERAPY, 2000, 11 (10) :1397-1406
[9]  
Komata T, 2001, CANCER RES, V61, P5796
[10]  
Lin TY, 2002, CANCER RES, V62, P3620